Prostate Cancer Treatment in Brevard County
The treatment that’s right for you depends on the grade of the tumor (the Gleason score), your risk group, the stage of cancer, and your overall health condition. Your prostate cancer doctor will talk with you about whether treatments need to begin right away. When it’s time to start treatments, the doctor will discuss the options and the expected results of each, including possible side effects. There are quite a few options other than surgery to treat prostate cancer.
Prostate cancer treatment may include one or more of the following treatments:
Risk Groups and Tests for Determining Prostate Cancer Treatment
When creating a customized treatment plan for each prostate cancer patient, the risk of cancer growth and spread is considered, especially when determining the right time to start treatment. Patients are classified into risk groups based on their biopsy results, PSA levels, and digital rectal exam findings.
Understanding Prostate Cancer Risk Groups
Prostate cancer is divided into three main risk groups:
- Low Risk
Prostate cancer in this group grows slowly, remains confined to the prostate, and has a low PSA level (less than 10). These cancers are typically small, low-grade, and often cause no symptoms. Tumors that can’t be felt during a digital rectal exam or those with no cancer detected in two prior biopsies are considered "very low risk." - Intermediate Risk
This group includes cancers confined to the prostate but with a higher PSA level (10-20) and Grade Groups 2 or 3. These cancers are growing quicker than low-risk prostate cancers. Oncologists often divide this group into "favorable" and "unfavorable" intermediate-risk categories based on additional factors.- Favorable intermediate risk means that the Gleason score was 3+4=7 and the PSA is less than 20. These cancers usually grow slower than unfavorable intermediate-risk prostate cancer, so treatment may not need to begin right away.
- Unfavorable intermediate risk means the Gleason score was 4+3=7 on the last biopsy. The primary cell pattern is more abnormal than it is normal, and treatment usually needs to start to avoid the cancer growing outside the prostate.
High Risk
High-risk cancers have typically spread outside the prostate, with a PSA level above 20 or a Grade Group of 4 or 5. Tumors that extend to nearby areas like the seminal vesicles, rectum, or bladder, or those with multiple high-grade biopsy samples, are classified as "very high risk."
Specialized Tests for Prostate Cancer Treatment Planning
In addition to risk grouping, advanced lab tests can provide detailed information about a tumor's biology to help predict how quickly the cancer might grow or spread. These tests may guide decisions about the best approach to treatment timing.
Oncotype DX Prostate: This test tracks specific genes in cancer cells taken from a biopsy and reports a score from 0 to 100. Higher scores indicate a cancer that is more likely to grow and spread quickly and has a higher risk of causing death from prostate cancer.
Decipher: This test measures the activity of specific genes in prostate cancer cells taken from a biopsy and creates a risk score on a scale from 0 to 1. A higher score means a higher likelihood of the cancer spreading beyond the prostate. For men undergoing surgery (prostatectomy) to treat their cancer, a similar test measures the activity of genes in prostate cancer cells from the surgery tissue. This can help determine the risk of the cancer recurring in other parts of the body after surgery and whether further treatment should be considered.
Prolaris: This test tracks a different set of genes in prostate cancer cells taken from a biopsy and provides a score on a scale from 0 to 10. A higher score indicates a cancer that is more likely to grow and spread quickly and has a higher risk of causing death from prostate cancer.
Be sure to talk with your oncologist about what to expect from these tests, including their accuracy and the information they can provide.
Active Surveillance (Watchful Waiting)
You may choose active surveillance if the risks and possible side effects of treatment outweigh the possible benefits. Your doctor may suggest active surveillance, also called watchful waiting, if you’re diagnosed with early-stage prostate cancer that seems to be slowly growing. Your doctor may also offer this option if you are older or have other serious health problems.
Choosing active surveillance doesn’t mean you’re giving up. It means you’re putting off the side effects of surgery or radiation therapy. Having surgery or radiation therapy is no guarantee that a man will live longer than a man who chooses to put off treatment.
If you and your doctor agree that active surveillance is a good idea, your doctor will check you regularly (such as every 3 to 6 months, at first). After about one year, your doctor may order another biopsy to check the Gleason score. You may begin treatment if your Gleason score rises, your PSA level starts to rise, or you develop symptoms. You’ll receive surgery, radiation therapy, or another approach.
Active surveillance avoids or delays the side effects of surgery and radiation therapy, but this choice has risks. For some men, it may reduce the chance to control cancer before it spreads. Also, it may be harder to cope with surgery or radiation therapy when you’re older.
If you choose active surveillance but grow concerned later, you should discuss your feelings with your doctor. Another approach is an option for most men.

Radiation Therapy for Prostate Cancer Treatment
Radiation therapy is an option for men with any stage of prostate cancer. Men with early stage prostate cancer may choose radiation therapy instead of surgery. It also may be used after surgery to destroy any cancer cells that remain in the area. In the later stages of prostate cancer, radiation treatment may be used to help relieve pain.
Radiation therapy (also called radiotherapy) uses high-energy rays to kill cancer cells. It affects cells only in the treated area.
Doctors use two types of radiation therapy to treat prostate cancer. Some men receive both types:
- Internal radiation (also known as prostate seed brachytherapy or implant radiation): The radiation comes from radioactive material that is typically contained in very small implants called seeds. The prostate seed brachytherapy procedure is minimally invasive and performed once, usually in an outpatient setting. Dozens of seeds containing radioactive isotopes are placed inside needles, and the needles are inserted into the prostate. The needles are removed, leaving the seeds behind with the goal of giving off radiation for months. They don’t need to be removed once the radiation is gone. Prostate cancer patients are given local or general anesthesia to block pain and help with relaxation during the procedure. Often, treatment takes just under one hour from start to finish. Data shows shorter recovery time, fewer long-term complications, and excellent long-term survival rates.
- External radiation: The radiation comes from a large machine outside the body. You will go to a hospital or clinic for treatment. Treatments are usually 5 days a week for several weeks. Many men receive 3-dimensional conformal radiation therapy or intensity-modulated radiation therapy. These types of treatment use computers to closely target the cancer to lessen the damage to healthy tissue near the prostate.
Our radiation oncologists also offer a more advanced approach called hypofractionated radiation therapy that gives the same dose of radiation in a shorter time period. The same results can be achieved in a 4-5 week course of radiation therapy, rather than 6-8 weeks, by giving a higher dose of radiation at each treatment. The exact number of treatment sessions depends on where the cancer is located, size, and the patient’s overall health condition. The shorter course of treatment is made possible through the more advanced delivery methods used with hypofractionated radiation therapy. The technology precisely aims the rays of radiation where the cancerous cells are treated with a higher dose while sparing nearby organs and tissues.
Both internal and external radiation can cause impotence during treatments. For most men, this improves after radiation therapy is complete. Other side effects can include fatigue and diarrhea. Talk with your prostate cancer doctor about ways to prepare for and manage the side effects of radiation therapy.
Cancer Care Centers of Brevard offers radiation therapy for prostate cancer treatment across Brevard County, including Melbourne, Merritt Island, and Palm Bay, Florida, so that it’s convenient for local residents to receive this type of cancer treatment.
Hormone Therapy for Prostate Cancer
A man with prostate cancer may have hormone therapy before, during, or after radiation therapy. Hormone therapy is also used alone for prostate cancer that has returned after treatment.
Male hormones (androgens) can cause prostate cancer to grow. Hormone therapy keeps prostate cancer cells from getting the male hormones they need to grow. The testicles are the body’s main source of the male hormone testosterone. The adrenal gland makes other male hormones and a small amount of testosterone.
Hormone therapy uses drugs or surgery:
-
Drugs: Your doctor may suggest a drug that can block natural hormones:
- Luteinizing hormone-releasing hormone (LH-RH) agonists: These drugs can prevent the testicles from making testosterone. Examples are leuprolide, goserelin, and triptorelin. The testosterone level falls slowly. Without testosterone, the tumor shrinks, or its growth slows. These drugs are also called gonadotropin-releasing hormone (GnRH) agonists.
- Antiandrogens: These drugs can block the action of male hormones. Examples are flutamide, bicalutamide, and nilutamide.
- Other drugs: Some drugs can prevent the adrenal gland from making testosterone. Examples are ketoconazole and aminoglutethimide.
- Surgery: Surgery to remove the testicles is called orchiectomy.
After orchiectomy or treatment with an LH-RH agonist, your body no longer gets testosterone from the testicles, the major source of male hormones. Because the adrenal gland makes small amounts of male hormones, you may receive an antiandrogen to block the action of the male hormones that remain. This combination of treatments is known as total androgen blockade (also called combined androgen blockade). However, studies have shown that total androgen blockade is no more effective than surgery or an LH-RH agonist alone.
Doctors usually treat prostate cancer that has spread to other parts of the body with hormone therapy. For some men, the cancer will be controlled for two or three years, but others will have a much shorter response to hormone therapy. In time, most prostate cancers can grow with very little or no male hormones, and hormone therapy alone is no longer helpful. At that time, your doctor may suggest chemotherapy or other forms of treatment that are under study. In many cases, the doctor may suggest continuing with hormone therapy because it may still be effective against some of the cancer cells.
Chemotherapy for Prostate Cancer
Chemotherapy may be used for prostate cancer that has spread and no longer responds to hormone therapy.
Surgery to Remove the Prostate
Surgery is an option for men with early (Stage I or II) prostate cancer. It’s sometimes an option for men with Stage III or IV prostate cancer. The surgeon may remove the whole prostate or only part of it.
Before the surgeon removes the prostate, the lymph nodes in the pelvis may be removed. If prostate cancer cells are found in the lymph nodes, the disease may have spread to other parts of the body. If cancer has spread to the lymph nodes, the surgeon does not always remove the prostate and may suggest other types of treatment.
There are several types of surgery for prostate cancer. Each type has benefits and risks. You and your doctor can talk about the types of surgery and which may be right for you:
- Open surgery: The surgeon makes a large incision (cut) into your body to remove the tumor. There are two approaches:
- Through the abdomen: The surgeon removes the entire prostate through a cut in the abdomen. This is called a radical retropubic prostatectomy.
- Between the scrotum and anus: The surgeon removes the entire prostate through a cut between the scrotum and the anus. This is called a radical perineal prostatectomy.
- Laparoscopic prostatectomy: The surgeon removes the entire prostate through small cuts, rather than a single long cut in the abdomen. A thin, lighted tube (a laparoscope) helps the surgeon remove the prostate.
- Robotic laparoscopic surgery: The surgeon removes the entire prostate through small cuts. A laparoscope and a robot are used to help remove the prostate. The surgeon uses handles below a computer display to control the robot’s arms.
- Cryosurgery: For some men, cryosurgery is an option. The surgeon inserts a tool through a small cut between the scrotum and anus. The tool freezes and kills prostate tissue. Cryosurgery is under study. See the section on Taking Part in Cancer Research.
- TURP: A man with advanced prostate cancer may choose TURP (transurethral resection of the prostate) to relieve symptoms. The surgeon inserts a long, thin scope through the urethra. A cutting tool at the end of the scope removes tissue from the inside of the prostate. TURP may not remove all of the cancer, but it can remove tissue that blocks the flow of urine.
Surgery can damage the nerves around the prostate. Damaging these nerves can make a man impotent (unable to have an erection). In some cases, your surgeon can protect the nerves that control erection. But if you have a large tumor or a tumor that’s very close to the nerves, surgery may cause impotence. Impotence can be permanent. You can talk with your doctor about medicine and other ways to help manage the sexual side effects of cancer treatment.
If your prostate is removed, you will no longer produce semen. You’ll have dry orgasms. If you wish to father children, you may consider sperm banking or a sperm retrieval procedure before surgery.

Clinical Trials for Prostate Cancer
Prostate cancer doctors at the Cancer Care Centers of Brevard participate in clinical trials to help patients receive the latest treatment options and to help patients across the country in the same way. The results of the clinical trials we participate in will advance the knowledge and treatments for patients everywhere. This provides them with new data and treatment options that were not available before. Before committing to participating in a clinical trial as part of prostate cancer treatment, there are a few things you should consider.
The Latest Prostate Cancer Treatments Are Available at Cancer Care Centers of Brevard
If you or a loved one have been recently diagnosed with a prostate cancer, the oncologists at Cancer Care Centers of Brevard are here to help you through your journey. We offer the latest treatments available with personalized treatment plans tailored to you. Our cancer centers are located throughout Brevard County, including Palm Bay, Rockledge, Melbourne, and Merrit Island,FL.